Trials / Completed
CompletedNCT01570452
Matrilysin Expression in Different Stages of Colorectal Tumors
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 38 (actual)
- Sponsor
- University of Roma La Sapienza · Academic / Other
- Sex
- All
- Age
- 40 Years – 83 Years
- Healthy volunteers
- Accepted
Summary
Matrix metalloproteinases (MMPs) have been shown to be involved in cancer biology. Significant expression of MMP-7 (matrilysin) in colorectal cancer is mainly associated with metastatic disease even though it is expressed in most tumor states. Our purpose is to analyse MMP-7 in bowel and lymph nodes of different tumor stages and to evaluate its expression as a potential biomarker of cancer disease in patients surgically treated for benign and malignant colorectal tumors. Tumoral tissue, lymph nodes and serum samples from recruited Patients plus serum samples from healthy volunteers are analysed for matrilysin expression by histology, immunohistochemistry, ELISA and Western blotting. If Matrilysin increases with increasing dysplasia and cancer disease stage in tumor tissue as well as in the regional lymph nodes it might be used as a complement in investigating suspected locally advanced cancer.
Conditions
- Colorectal Cancer Stage 0
- Colorectal Cancer Stage I
- Colorectal Cancer Stage II
- Colorectal Cancer Stage III
- Colorectal Cancer Stage IV
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | colonic or colorectal resection | standard laparotomic resection of colon-rectum including right hemicolectomy, left hemicolectomy, sigmoidectomy, anterior resection |
Timeline
- Start date
- 2005-09-01
- Primary completion
- 2008-09-01
- Completion
- 2012-02-01
- First posted
- 2012-04-04
- Last updated
- 2012-04-04
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01570452. Inclusion in this directory is not an endorsement.